79258665 - GENOSCIENCE PHARMA

Information

• Trademark
• 79258665

• Source

• Serial Number

  79258665

• Registration Number

  6132420

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  February 01, 2019
  6 years ago

• Registration Date

  August 25, 2020
  4 years ago

• Transaction Date

  January 03, 2021
  4 years ago

• Status Date

  August 25, 2020
  4 years ago

• Published for Opposition Date

  June 09, 2020
  4 years ago

• Location Date

  August 25, 2020
  4 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  EULIN, INGRID C

• Attorney Name

  James R. Robinson

  Law Office Assigned Location Code

  M20

• Owners

  • Genoscience Pharma SAS

Case File Statements

• D10000: "PHARMA"
• GS0011: Active chemical ingredients used in the manufacture of anti-cancer drugs; chemical products intended for pharmaceutical sciences, namely, chemical additives for use in the manufacture of pharmaceuticals; preserving agents for the pharmaceutical industry, namely, preservatives for use in the pharmaceutical industry; antioxidants for the manufacture of pharmaceutical products; chemical preparations for be used in the manufacture of pharmaceutical products, namely, active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer-related diseases or conditions; chemicals for use in biotechnological product development; enzymes derived from biotechnological processes for industrial use; chemicals used in biotechnological manufacturing processes; diagnostic preparations and diagnostic reagents for scientific or research use; reagents and solvents for sample preparation, modification and manipulation of cells, as well as for the implementation of marking methods, separation, isolation, reproduction and/or cleaning of biopolymers, nucleic acids, proteins, macromolecules, namely, reagents for scientific use and biologically active substances for diagnostic use, namely, biologically active enzymes and microorganisms that are aimed as sanitizing water environments and to treat the activation and optimization of biological filter systems
• GS0051: Pharmaceutical preparations, pharmaceutical products, and pharmaceutical substances, namely, pharmaceutical preparations for the treatment of cancer-related diseases or conditions; pharmaceutical preparations for cancer treatment; biopharmaceutical products for cancer treatment, namely, biological preparations for the treatments of cancer; pharmaceutical products for cancer treatment; pharmaceutical preparations and substances for cancer prevention; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for cancer prevention and treatment; biotechnological preparations for medical use, namely, biological tissue cultures for medical purposes; diagnostic agents for medical use; strips for medical diagnosis, namely, medical diagnostic test strips for cancer diagnosis; diagnostic preparations for medical use; diagnostic reagents for medical use; diagnostic substances for medical use; pharmaceutical medicine products and diagnostic products for sample preparation, modification and manipulation of cells and for marking, separation, isolation, reproduction and/or cleaning of biopolymers, nucleic acids, proteins, macromolecules and biologically active substances, namely, chemical reagents for medical purposes
• GS0421: Development of new technology on behalf of third parties in the field of genetics and biotechnology; biotechnological processes for regulating, modifying and characterizing of disease conditions, medical research specialized in the biotechnological field with respect to regulating, modifying and characterizing diseases or conditions; research and development for third parties in the field of biotechnology; manufacturing and consolidating upon request of DNA, biological organisms, cells, viruses, pathogens, special cells which have been genetically modified according to the specification of third parties for scientific, medical and laboratory use and for research, namely, medical and scientific laboratory services; gene therapy services for third parties, namely, scientific research and product development regarding DNA, biological organisms, cells, viruses, pathogens and special cells which have been genetically modified for scientific and medical use and for research; scientific and technological services, namely, research and design in the field of medical treatment, namely, cancer treatment; industrial analysis and research services, namely, testing, analysis and evaluation of drugs for treatment of cancer and cancer-related diseases and conditions to assure compliance with industry and regulatory standards; research and development of anti-cancer drugs; development of pharmaceutical preparations and medicines; development of pharmaceutical products; development of chemical compounds, namely, custom design and development of reagents and biochemical assays; research and development of new products for others with respect to chemical compounds for therapeutic use; pharmaceutical drug development services for anti-cancer drugs; evaluation of pharmaceutical products; research in the field of pharmaceutical products, namely, pharmaceutical research and development; pharmaceutical research and development in the field of anti-cancer drugs; pharmaceutical research and development services; pharmaceutical research; carrying out clinical trials for pharmaceutical products, namely, conducting clinical trials for others; conducting cancer treatment clinical trials for others; provision of medical and scientific research information concerning the results of clinical trials for pharmaceutical products; laboratory research services in the field of pharmaceuticals; laboratory research services for cancer treatment; testing, inspection and research services in the field of pharmaceuticals; testing, inspection and research for pharmaceuticals for cancer treatment; biotechnological research services; preparation of reports in the field of biotechnology; research and development in the field of biotechnology; services provided by consultants in the field of biotechnology, namely, scientific research consulting in the field of biotechnology; providing scientific research information in the biochemical and biotechnological fields; product design and development in the field of medical and pharmaceutical diagnostic apparatus
• GS0441: Medical analysis services for diagnosing cancer; medical analysis of RNA or DNA for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis; colorectal cancer screening services; medical services for diagnosing diseases; medical diagnosis of cancer-related diseases or conditions; medical testing for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis; medical testing and analysis for diagnostic or treatment purposes
• PM0001: GENO SCIENCE PHARMACEUTICAL

Case File Event Statements

• 1/3/2021 - 4 years ago

  30 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 12/16/2020 - 4 years ago

  29 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 12/15/2020 - 4 years ago

  28 - FINAL DISPOSITION PROCESSED Type: FIMP

• 11/25/2020 - 4 years ago

  27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 8/25/2020 - 4 years ago

  26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/9/2020 - 4 years ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/9/2020 - 4 years ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/5/2020 - 4 years ago

  23 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 5/20/2020 - 4 years ago

  22 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 5/20/2020 - 4 years ago

  21 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 5/20/2020 - 4 years ago

  20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/4/2020 - 4 years ago

  19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/30/2020 - 4 years ago

  18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/30/2020 - 4 years ago

  17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/30/2020 - 4 years ago

  16 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 1/13/2020 - 5 years ago

  15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 1/13/2020 - 5 years ago

  14 - FINAL REFUSAL E-MAILED Type: GNFR

• 1/13/2020 - 5 years ago

  13 - FINAL REFUSAL WRITTEN Type: CNFR

• 12/18/2019 - 5 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/18/2019 - 5 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/18/2019 - 5 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/12/2019 - 5 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 6/24/2019 - 5 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 6/24/2019 - 5 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 6/4/2019 - 5 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 6/3/2019 - 5 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/24/2019 - 5 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 5/20/2019 - 5 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 5/20/2019 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 5/16/2019 - 5 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR